Aethlon Medical Inc (AEMD) income statement
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
$5.46+0.62 (+12.81%)
Close on Nov 20, 2026Market cap $3.88MP/E –Yield –
Aethlon Medical Inc financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $3.88MP/E –Yield –
See a number that looks wrong?
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||||||||||
| Operating margin | – | – | – | -2,072.0% | -3,542.5% | -1,197.3% | -912.0% | -2,612.5% | -3,228.8% | -1,555.4% | -494.6% | -523.7% | -188.2% | -290.7% | -229.1% | – | – |
| EBITDA margin | – | – | – | -2,030.1% | -3,500.5% | -1,191.2% | -908.0% | -2,599.2% | -3,205.0% | -1,547.1% | -490.2% | -518.8% | -186.9% | -289.8% | -227.8% | – | – |
| Net profit margin | – | – | – | -2,094.9% | -3,540.9% | -1,196.6% | -980.3% | -2,697.8% | -3,795.9% | -1,855.8% | -549.6% | -891.5% | -822.6% | -397.7% | -596.6% | – | – |
| Free cash flow margin | – | – | – | -1,993.6% | -3,439.0% | -1,035.5% | -822.7% | -1,869.8% | -2,630.2% | -898.4% | -489.4% | -662.3% | -137.6% | -170.6% | -135.6% | – | – |
| Returns on capital | |||||||||||||||||
| Return on equity | -142.9% | -245.9% | -117.2% | -75.1% | -78.8% | -83.7% | -107.7% | -144.8% | -166.8% | -652.8% | -449.4% | 94.8% | 110.9% | 53.1% | 106.2% | 110.1% | – |
| Return on assets | -104.5% | -171.6% | -94.8% | -65.2% | -69.2% | -74.9% | -87.9% | -108.0% | -125.1% | -342.0% | -249.2% | -442.0% | -1,218.8% | -732.7% | -1,153.9% | -1,006.9% | – |
| Return on tangible assets | -104.5% | -171.6% | -94.8% | -65.2% | -69.3% | -75.3% | -88.6% | -109.2% | -127.3% | -356.2% | -261.9% | -473.8% | -1,358.3% | -895.9% | -1,417.7% | -1,336.8% | – |
| Return on capital employed | -141.0% | -157.3% | -112.7% | -70.8% | -77.5% | -84.8% | -102.1% | -130.8% | -121.0% | -391.3% | -312.2% | 60.7% | 26.5% | 38.8% | 40.8% | 76.3% | – |
| NOPAT | -$5.76M | -$7.38M | -$9.98M | -$9.40M | -$8.23M | -$6.23M | -$4.68M | -$4.74M | -$3.82M | -$4.82M | -$3.46M | -$3.15M | -$2.41M | -$2.82M | -$2.46M | -$3.60M | – |
| Cash flow quality | |||||||||||||||||
| OCF / Sales | – | – | – | -1,829.4% | -3,320.3% | -1,026.4% | -799.4% | -1,869.8% | -2,613.7% | -894.2% | -488.3% | -662.3% | -131.7% | -170.6% | -135.4% | – | – |
| OCF / Net income | 0.98 | 0.57 | 0.83 | 0.87 | 0.94 | 0.86 | 0.82 | 0.69 | 0.69 | 0.48 | 0.89 | 0.74 | 0.16 | 0.43 | 0.23 | 0.34 | – |
| FCF / OCF | 100.1% | 100.0% | 102.5% | 109.0% | 103.6% | 100.9% | 102.9% | 100.0% | 100.6% | 100.5% | 100.2% | 100.0% | 104.5% | 100.0% | 100.1% | 100.1% | – |
| FCF / Net income | 0.98 | 0.57 | 0.85 | 0.95 | 0.97 | 0.87 | 0.84 | 0.69 | 0.69 | 0.48 | 0.89 | 0.74 | 0.17 | 0.43 | 0.23 | 0.35 | – |
| FCF / EBITDA | 100.5% | 84.9% | 84.6% | 98.2% | 98.2% | 86.9% | 90.6% | 71.9% | 82.1% | 58.1% | 99.8% | 127.7% | 73.6% | 58.9% | 59.5% | 43.4% | – |
| Unlevered free cash flow | -$6.99M | -$7.64M | -$10.38M | -$11.45M | -$10.12M | -$6.82M | -$5.35M | -$4.29M | -$3.94M | -$3.52M | -$4.24M | -$4.81M | -$1.22M | -$2.10M | -$1.84M | -$1.97M | – |
| Levered free cash flow | -$7.00M | -$7.65M | -$10.38M | -$11.45M | -$10.12M | -$6.82M | -$5.35M | -$4.29M | -$3.94M | -$3.52M | -$4.34M | -$5.05M | -$2.24M | -$2.10M | -$1.84M | -$1.97M | – |
| Efficiency | |||||||||||||||||
| Asset turnover | – | – | 0.00 | 0.03 | 0.02 | 0.06 | 0.09 | 0.04 | 0.03 | 0.18 | 0.45 | 0.50 | 1.48 | 1.84 | 1.93 | – | – |
| Fixed asset turnover | – | – | 0.00 | 0.72 | 0.98 | 4.37 | 8.88 | 13.68 | 5.27 | 12.02 | 19.25 | 10.86 | 38.47 | 1,527.96 | 293.97 | – | – |
| Receivables turnover | – | – | – | 8.98 | 2.12 | 3.70 | 6.29 | 6.14 | 4.00 | 3.93 | 4.51 | 5.29 | 10.68 | 4.04 | 3.40 | – | – |
| Days sales outstanding | – | – | – | 40.7 | 171.9 | 98.5 | 58.0 | 59.5 | 91.3 | 92.8 | 80.9 | 69.1 | 34.2 | 90.3 | 107.4 | – | – |
| CapEx to revenue | – | – | – | 164.2% | 118.7% | 9.1% | 23.3% | 0.00% | 16.6% | 4.2% | 1.0% | 0.00% | 5.9% | 0.00% | 0.13% | – | – |
| CapEx to OCF | -0.05% | -0.00% | -2.5% | -9.0% | -3.6% | -0.89% | -2.9% | -0.00% | -0.63% | -0.47% | -0.21% | -0.00% | -4.5% | -0.00% | -0.09% | -0.13% | – |
| CapEx to depreciation | 0.01 | 0.00 | 0.70 | 3.92 | 2.82 | 1.50 | 5.75 | 0.00 | 0.70 | 0.51 | 0.24 | 0.00 | 4.56 | 0.00 | 0.10 | 0.13 | – |
| Liquidity | |||||||||||||||||
| Current ratio | 3.85 | 3.13 | 3.40 | 10.03 | 9.95 | 7.53 | 9.40 | 2.21 | 15.13 | 2.61 | 4.51 | 2.10 | 0.09 | 0.04 | 0.07 | 0.06 | – |
| Quick ratio | 3.85 | 3.13 | 3.40 | 10.03 | 9.95 | 7.53 | 9.40 | 2.21 | 15.13 | 2.61 | 4.51 | 2.10 | 0.09 | 0.04 | 0.07 | 0.06 | – |
| Cash ratio | 3.47 | 2.95 | 3.02 | 0.17 | 9.41 | 7.20 | 9.00 | 2.10 | 14.59 | 2.55 | 4.03 | 1.49 | 0.08 | 0.01 | 0.01 | 0.00 | – |
| Working capital | $4.12M | $4.05M | $4.40M | $13.59M | $16.33M | $8.98M | $8.97M | $2.21M | $6.75M | $985.50K | $1.85M | $630.42K | -$14.17M | -$9.28M | -$9.44M | -$6.13M | – |
| Net current asset value | $4.12M | $3.71M | $3.75M | $12.65M | $15.73M | $8.98M | $8.93M | $2.21M | $5.91M | $466.30K | $1.35M | $475.19K | -$14.95M | -$9.28M | -$9.44M | -$6.13M | – |
| Leverage | |||||||||||||||||
| Assets to equity | 1.30 | 1.44 | 1.43 | 1.16 | 1.14 | 1.13 | 1.10 | 1.70 | 1.20 | 2.55 | 1.63 | 2.24 | -0.11 | -0.05 | -0.09 | -0.09 | – |
| Intangibles to total assets | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% | 0.53% | 0.55% | 1.6% | 1.0% | 4.9% | 3.7% | 7.5% | 6.6% | 24.5% | 15.6% | 24.7% | – |
| Interest coverage | |||||||||||||||||
| EBIT / Interest expense | -507.49 | -924.06 | – | – | – | – | – | – | – | – | -34.90 | -13.40 | -2.37 | – | – | – | – |
| EBITDA / Interest expense | -484.97 | -890.47 | – | – | – | – | – | – | – | – | -34.59 | -13.27 | -2.36 | – | – | – | – |
| (EBITDA − CapEx) / Interest expense | -485.23 | -890.47 | – | – | – | – | – | – | – | – | -34.67 | -13.27 | -2.43 | – | – | – | – |
| Per share | |||||||||||||||||
| Revenue per share | – | – | 0.00 | 19.98 | 15.26 | 34.20 | 55.53 | 144.97 | 101.23 | 534.89 | 1,396.18 | 1,373.72 | 4,330.05 | 4,256.07 | 6,936.84 | – | – |
| EPS (basic) | -10.61 | -85.77 | -388.70 | -468.80 | -568.00 | -520.00 | -1,496.00 | -4,104.00 | -1,200.00 | -11,280.00 | -7,920.00 | -14,640.00 | -41,280.00 | -18,000.00 | -48,000.00 | -48,000.00 | – |
| EPS (diluted) | -10.61 | -85.77 | -388.70 | -468.80 | -568.00 | -520.00 | -1,496.00 | -4,104.00 | -1,200.00 | -11,280.00 | -7,920.00 | -14,640.00 | -41,280.00 | -18,000.00 | -48,000.00 | -48,000.00 | – |
| Book value per share | 15.56 | 25.48 | 175.41 | 524.14 | 881.57 | 489.29 | 803.62 | 1,531.00 | 4,150.23 | 922.75 | 2,445.23 | 1,108.92 | -39,862.50 | -31,641.67 | -47,426.64 | -46,323.24 | – |
| Tangible book value per share | 15.56 | 25.48 | 175.38 | 524.08 | 881.46 | 486.34 | 798.71 | 1,488.91 | 4,098.92 | 806.80 | 2,296.94 | 922.75 | -40,162.47 | -32,062.62 | -48,094.07 | -47,408.36 | – |
| Cash per share | 16.00 | 27.85 | 168.21 | 8.70 | 890.31 | 514.08 | 820.29 | 2,416.71 | 4,718.59 | 2,127.83 | 3,344.47 | 1,541.61 | 3,334.08 | 433.47 | 734.22 | 121.74 | – |
| Operating cash flow per share | -22.28 | -38.02 | -308.15 | -365.51 | -506.75 | -350.99 | -443.90 | -2,710.50 | -2,645.93 | -4,782.95 | -6,817.81 | -9,098.04 | -5,703.92 | -7,262.48 | -9,394.67 | -15,258.40 | – |
| Free cash flow per share | -22.29 | -38.02 | -315.78 | -398.32 | -524.87 | -354.09 | -456.85 | -2,710.50 | -2,662.72 | -4,805.37 | -6,832.46 | -9,098.04 | -5,960.07 | -7,262.48 | -9,403.52 | -15,278.09 | – |
| CapEx per share | 0.01 | 0.00 | 7.63 | 32.81 | 18.12 | 3.11 | 12.95 | 0.00 | 16.79 | 22.42 | 14.66 | 0.00 | 256.15 | 0.00 | 8.85 | 19.70 | – |
| Valuation at period end | |||||||||||||||||
| Market cap | $10.66M | $25.04M | $21.81M | $43.64M | $112.48M | $123.05M | $36.33M | $88.23M | $91.46M | $127.16M | $204.22M | $376.74M | $198.93M | $90.09M | $54.60M | – | – |
| Enterprise value | $3.70M | $20.21M | $13.84M | $26.14M | $91.94M | $110.78M | $32.14M | $83.28M | $85.75M | $126.46M | $200.92M | $374.04M | $197.34M | $89.98M | $54.25M | – | – |
| P/S | – | – | – | 76.0x | 382x | 187x | 55.9x | 384x | 611x | 324x | 230x | 494x | 123x | 73.2x | 40.2x | – | – |
| P/B | 2.2x | 4.9x | 3.8x | 2.9x | 6.6x | 13.0x | 3.9x | 36.4x | 14.9x | 188x | 132x | 612x | -13.3x | -9.9x | -5.9x | – | – |
| P/TBV | 2.2x | 4.9x | 3.8x | 2.9x | 6.6x | 13.1x | 3.9x | 37.4x | 15.1x | 215x | 140x | 736x | -13.2x | -9.7x | -5.8x | – | – |
| P/OCF | -1.5x | -3.3x | -2.2x | -4.2x | -11.5x | -18.2x | -7.0x | -20.6x | -23.4x | -36.3x | -47.2x | -74.6x | -93.0x | -42.9x | -29.7x | – | – |
| EV/Sales | – | – | – | 45.5x | 313x | 168x | 49.4x | 363x | 573x | 323x | 227x | 491x | 122x | 73.2x | 39.9x | – | – |
| EV/OCF | -0.5x | -2.6x | -1.4x | -2.5x | -9.4x | -16.4x | -6.2x | -19.4x | -21.9x | -36.1x | -46.4x | -74.1x | -92.3x | -42.9x | -29.5x | – | – |
| Earnings yield | -67.1% | -53.5% | -56.0% | -27.6% | -9.3% | -6.4% | -17.5% | -7.0% | -6.2% | -5.7% | -2.4% | -1.8% | -6.7% | -5.4% | -14.9% | – | – |
| FCF yield | -65.7% | -30.5% | -47.6% | -26.2% | -9.0% | -5.5% | -14.7% | -4.9% | -4.3% | -2.8% | -2.1% | -1.3% | -1.1% | -2.3% | -3.4% | – | – |
| Shareholder yield | |||||||||||||||||
| Buyback yield | – | – | – | – | – | – | – | 0.22% | 0.30% | 0.30% | -2.7% | – | – | – | – | – | – |
| Shareholder yield | – | – | – | – | – | – | – | 0.22% | 0.30% | 0.30% | -2.7% | – | – | – | – | – | – |
| Cost structure | |||||||||||||||||
| R&D to revenue | – | – | – | 478.0% | 795.8% | 314.4% | 142.6% | 390.2% | 391.6% | 171.7% | 88.2% | 134.8% | 92.9% | 117.1% | – | – | – |
| Stock-based comp to revenue | – | – | – | 183.2% | 255.2% | 118.3% | 129.8% | 574.4% | 842.6% | 557.6% | 22.9% | 54.6% | 37.4% | 62.2% | 55.8% | – | – |
| Per employee | |||||||||||||||||
| Total employees | 9 | 9 | 14 | 15 | 14 | 10 | 8 | 6 | 6 | 7 | 5 | 5 | 7 | 9 | 9 | 6 | 4 |
| Revenue per employee | – | – | – | $38.28K | $21.01K | $65.91K | $81.27K | $38.27K | $24.94K | $56.01K | $177.31K | $152.48K | $231.97K | $136.67K | $151.07K | – | – |
| Operating profit per employee | -$810.40K | -$1.04M | -$902.61K | -$793.24K | -$744.35K | -$789.15K | -$741.25K | -$999.84K | -$805.19K | -$871.19K | -$876.97K | -$798.57K | -$436.56K | -$397.26K | -$346.04K | -$759.52K | – |
| Net income per employee | -$794.61K | -$1.49M | -$872.01K | -$801.99K | -$744.01K | -$788.67K | -$796.74K | -$1.03M | -$946.59K | -$1.04M | -$974.47K | -$1.36M | -$1.91M | -$543.56K | -$901.26K | -$951.91K | – |
| Free cash flow per employee | -$778.01K | -$849.50K | -$741.48K | -$763.22K | -$722.60K | -$682.48K | -$668.66K | -$715.57K | -$655.92K | -$503.19K | -$867.72K | -$1.01M | -$319.29K | -$233.21K | -$204.79K | -$328.48K | – |
| Growth | |||||||||||||||||
| Revenue 1Y growth | – | – | -100.0% | 95.2% | -55.4% | 1.4% | 183.2% | 53.5% | -61.8% | -55.8% | 16.3% | -53.0% | 32.0% | -9.5% | – | – | – |
| Revenue 3Y CAGR | – | – | – | -4.1% | 8.6% | 63.9% | 18.4% | -36.3% | -41.9% | -37.7% | -10.3% | -17.5% | – | – | – | – | – |
| Revenue 5Y CAGR | – | – | – | 30.9% | -5.6% | -5.8% | -3.1% | -32.4% | -34.4% | -22.0% | – | – | – | – | – | – | – |
| Revenue 10Y CAGR | – | – | – | -7.3% | -14.2% | – | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | 21.9% | 26.1% | -6.2% | -14.2% | -32.1% | -33.1% | 1.2% | -24.2% | 20.8% | -39.1% | -9.8% | -30.7% | 14.5% | -14.8% | 31.7% | – | – |
| EBITDA 1Y growth | 22.6% | 26.7% | -5.3% | -13.2% | -31.1% | -33.0% | 1.1% | -24.5% | 20.9% | -39.6% | -9.9% | -30.3% | 14.9% | -15.1% | 31.8% | – | – |
| Net income 1Y growth | 46.6% | -9.7% | -1.5% | -15.5% | -32.1% | -23.7% | -2.9% | -9.1% | 21.9% | -49.3% | 28.3% | 49.1% | -173.0% | 39.7% | -42.0% | – | – |
| Diluted EPS 1Y growth | 87.6% | 77.9% | 17.1% | 17.5% | -9.2% | 65.2% | 63.5% | -242.0% | 89.4% | -42.4% | 45.9% | 64.5% | -129.3% | 62.5% | 0.00% | – | – |
| Operating cash flow 1Y growth | 8.5% | 24.5% | 3.6% | -7.6% | -44.4% | -30.2% | -21.1% | -9.8% | -11.5% | 19.0% | 14.3% | -136.1% | -1.9% | -14.0% | 6.5% | – | – |
| Free cash flow 1Y growth | 8.4% | 26.3% | 9.3% | -13.2% | -48.2% | -27.6% | -24.6% | -9.1% | -11.7% | 18.8% | 14.1% | -125.9% | -6.5% | -13.9% | 6.5% | – | – |
| CapEx 1Y growth | – | -100.0% | -73.4% | 170.1% | 483.1% | -60.5% | – | -100.0% | 51.1% | 76.6% | – | -100.0% | – | -100.0% | -31.7% | – | – |
| CapEx 3Y CAGR | -84.2% | – | 61.2% | 83.9% | – | 34.1% | 109.8% | – | – | -44.5% | – | – | 235.6% | – | – | – | – |
| CapEx 5Y CAGR | -42.7% | – | – | 107.0% | 84.3% | 45.1% | – | – | – | 56.8% | 29.6% | – | – | – | – | – | – |
| CapEx 10Y CAGR | -8.8% | – | 10.1% | – | 70.0% | 37.2% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -13.9% | -10.8% | -52.9% | -9.8% | 82.0% | 2.7% | 151.9% | -43.9% | 325.9% | -31.7% | 83.2% | -18.6% | 241.3% | -40.8% | 47.9% | – | – |
| Total assets 3Y CAGR | -28.7% | -27.6% | -8.2% | 19.0% | 67.6% | 13.2% | 81.9% | 17.7% | 74.6% | 0.61% | 72.0% | 18.1% | 44.0% | – | – | – | – |
| Total assets 5Y CAGR | -9.9% | -6.7% | 14.9% | 19.0% | 62.3% | 33.4% | 49.7% | 19.5% | 71.4% | 15.5% | 34.8% | – | – | – | – | – | – |
| Total assets 10Y CAGR | 9.6% | 18.2% | 17.1% | 42.8% | 36.9% | 34.1% | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -4.6% | -11.1% | -61.7% | -11.3% | 80.2% | 0.22% | 288.0% | -60.5% | 806.9% | -56.4% | 152.3% | 104.1% | -63.5% | 1.6% | -55.6% | -35.7% | – |
| Total equity 3Y CAGR | -31.3% | -32.9% | -15.1% | 17.0% | 91.4% | 15.4% | 140.5% | 16.0% | 115.2% | – | – | – | – | – | – | – | – |
| Total equity 5Y CAGR | -12.3% | -11.4% | 18.9% | 19.7% | 90.5% | 43.4% | 72.5% | – | – | – | – | – | – | – | – | – | – |
| Total equity 10Y CAGR | 12.1% | 23.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.